Mission BioCapital | Activity | F4

Team Portfolio Raise Champions Essays

F4/Mission BioCapital/Activity

Mission BioCapital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

News

Opened the $4 million 2026 Platinum Program contest and announced 2025 Platinum Ticket investments.

2026 Platinum Program contest opens, 2025 Platinum Ticket investments

Mission BioCapital

missionbiocapital.comAPR 2, 2026

APR 2, 2026

Exit

Portfolio company SiteOne Therapeutics was acquired by Lilly.

SiteOne Therapeutics

SiteOne Therapeutics Mission BioCapital

missionbiocapital.comMAY 27, 2025

MAY 27, 2025

News

Expanded into the Nordic region with an office and incubator partnership at BioInnovation Institute in Copenhagen.

Copenhagen office at BioInnovation Institute

Mission BioCapital

missionbiocapital.comAPR 30, 2025

APR 30, 2025

News

Announced 2024 Platinum Ticket investments and opened the $4 million 2025 Platinum Program contest.

2024 Platinum Ticket investments, 2025 Platinum Program contest

Mission BioCapital

missionbiocapital.comAPR 7, 2025

APR 7, 2025

Exit

Sanofi agreed to acquire Dren Bio's bispecific myeloid cell engager.

Dren Bio

Dren Bio Mission BioCapital

missionbiocapital.comMAR 24, 2025

MAR 24, 2025

Team Change

Announced team promotions and new hires.

Team promotions and new hires

Mission BioCapital

missionbiocapital.comFEB 5, 2025

FEB 5, 2025

News

Announced the first Platinum Program winners and inaugural service sponsors.

First Platinum Program winners

Mission BioCapital

missionbiocapital.comOCT 30, 2024

OCT 30, 2024

New Fund

Announced the $275 million Fund V.

Fund V

Mission BioCapital

missionbiocapital.comNOV 4, 2021

NOV 4, 2021